2-Phenyl-4(5)-[[4-(pyrimidin-2- yl)piperazin-1-yl]methyl]imidazole. A Highly Selective Antagonist at Cloned Human D4 Receptors
- 1 January 1997
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (1) , 1-3
- https://doi.org/10.1021/jm960637m
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- 3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 ReceptorJournal of Medicinal Chemistry, 1996
- Antipsychotic-Induced Tardive DyskinesiaCNS Drugs, 1995
- Absence of detectable striatal dopamine D4 receptors in drug-treated schizophreniaEuropean Journal of Pharmacology, 1995
- Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophreniaJournal of Neuroscience, 1995
- Adverse effects of antipsychotic drugsInternational Clinical Psychopharmacology, 1995
- Dopamine D4 receptors elevated in schizophreniaNature, 1993
- Prepulse inhibition as a screening test for potential antipsychoticsDrug Development Research, 1991
- Neurochemical modulation of sensory-motor reactivity: Acoustic and tactile startle reflexesNeuroscience & Biobehavioral Reviews, 1980